Let’s dig into the relative performance of Cigna (NYSE:CI) and its peers as we unravel the now-completed Q4 health insurance ...

Cigna Group (NYSE:CI) has seen its share price increase by 11% over the last quarter amid various significant events within the company. Recently announced executive changes include Brian Evanko being ...

Cigna delivered a strong Q4 performance, with revenue surging 28.4% year over year to $65.65 billion. This exceeded analyst ...

All but Cigna were among the portfolio's top-10 holdings ... We avoided these benchmark components in Q4, as we did not see compelling value opportunities among these names. Throughout the quarter ...

Q4 2024 Results Conference Call March 10, 2025 4:30 PM ETCompany ParticipantsJustin Schreiber - Chairman and Chief ...

We recently compiled a list of the Top 10 Health Insurance Stocks To Buy. In this article, we are going to take a look at ...

Health insurance company Cigna (NYSE:CI) announced better-than-expected revenue in Q4 CY2024, with sales up 28.4% year on year to $65.65 billion. The company expects the full year’s revenue to be ...

Cigna reported fourth-quarter 2024 adjusted earnings per share of $6.64, which missed the Zacks Consensus Estimate by 15.2% due to a decline in its overall medical customer base and elevated ...

Newron Pharmaceuticals S.p.A. ("Newron") (SIX: NWRN, XETRA: NP5), a biopharmaceutical company focused on the development of novel therapies for diseases of the central and peripheral nervous system, ...

Twist Bioscience Corporation , a core mid-cap growth and value equity company in the life sciences segment of the health care sector, today announced that, for a limited time, all Twist Express Genes ...

Wrapping up Q4 earnings, we look at the numbers and key ... Serving both corporate clients and individual customers, Cigna (NYSE:CI) offers health insurance and pharmacy benefit management ...